Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...

Of the amount earned in 2024, $1.6 million came from Michael’s salary, which increased a little less than $200,000 compared with 2023 as part of his promotion, AbbVie said in its 2025 proxy ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Feb 18 (Reuters) - HSBC (HSBA.L), opens new tab on Tuesday agreed to sell its retail banking operations in Bahrain to Bank of Bahrain and Kuwait (BBK) (BBKB.BH), opens new tab amid a global ...

For the first time, pharmacists in the US will be able to substitute a cheaper biosimilar version when they receive a prescription for AbbVie’s high-concentration formulation of Humira ...

Williams driver Carlos Sainz set the pace on the second day of F1 2025 pre-season testing in Bahrain. Sainz’s quickest lap of 1:29.348 was 0.031 seconds faster than Lewis Hamilton’s Ferrari ...

The F1 2025 season began in earnest today as the drivers took to the Bahrain International Circuit for pre-season testing. Despite the season opener being in Melbourne, the Australian venue’s ...

The 10 teams have just three days this week from Wednesday to Friday at the Bahrain International Circuit to prepare for the season-opening Australian Grand Prix on March 16, and you can watch it ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional ...